Editor's note: Welcome to Stockpickr's "Barron's Roundup." Each weekend, James Altucher presents Stockpickr portfolios related to articles in the latest issue of Barron's.
ranks brokers by the accuracy of their buy recommendations. The top-ranking brokers are bullish on
Pharmaceutical Product Development
, and bearish on
Research In Motion
interviews Praveen Gottipalli, director of equity investments at Symphony Asset Management. Symphony uses quantitative and fundamental principles while hedging against market risk. Gottipalli currently likes
: Each week,
publishes bullish and bearish stories on a variety of stocks. We present summaries of those stories in this portfolio. This week, there are bullish stories on
, and bearish pieces on
: Which companies are the top hedge funds chasing? This week's list includes names like
True Religion Apparel
: The latest analyst research highlighted by
, including reports this week on
Abercrombie & Fitch
: Insider purchases are a lot more predictive than insider selling.
lists companies where managers are buying stock, and we build a portfolio with those companies' stocks. There has been interesting activity in
At the time of publication, Altucher and/or his fund had no holdings of stocks mentioned, although positions may change at any time.
James Altucher is president of
LLC, a wholly owned subsidiary of TheStreet.com and part of its network of Web properties, and a managing partner at Formula Capital, an alternative asset management firm that runs a fund of hedge funds. He is also a weekly columnist for the
and the author of
Trade Like a Hedge Fund
Trade Like Warren Buffett
. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback;
to send him an email.
TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.